Kumar A, Arora A, Sharma P, et al. Clinical Features of COVID-19 and factors associated with severe clinical course: a systematic review and meta-analysis. SSRN [Preprint]. 2020. https://doi.org/10.2139/ssrn.3566166.
Article
PubMed
PubMed Central
Google Scholar
Chua RL, Lukassen S, Trump S, et al. COVID-19 severity correlates with airway epithelium-immune cell interactions identified by single-cell analysis. Nat Biotechnol. 2020;38(8):970–9. https://doi.org/10.1038/s41587-020-0602-4 (Epub 2020 Jun 26 PMID: 32591762).
Article
CAS
PubMed
Google Scholar
Hu B, Huang S, Yin L. The cytokine storm and COVID-19. J Med Virol. 2021;93:250–6. https://doi.org/10.1002/jmv.26232.
Article
CAS
PubMed
Google Scholar
Zhou F, Yu T, Du R, et al. Clinical course and risk factors for mortality of adult inpatients with COVID-19 in Wuhan, China: a retrospective cohort study. Lancet. 2020;395:1054–62.
Article
CAS
Google Scholar
Varga Z, Flammer AJ, Steiger P, et al. Endothelial cell infection and endotheliitis in COVID-19. Lancet. 2020;395:1417–8. https://doi.org/10.1016/S0140-6736(20)30937-5.
Article
CAS
PubMed
PubMed Central
Google Scholar
Bradley BT, Maioli H, Johnston R, et al. Histopathology and ultrastructural findings of fatal COVID-19 infections in Washington State: a case series. The Lancet. 2020;396(10247):320. https://doi.org/10.1016/S0140-6736(20)31305-2.
Article
CAS
Google Scholar
Chen X, Liao B, Cheng L, et al. The microbial coinfection in COVID-19. Appl Microbiol Biotechnol. 2020;104(18):7777–85. https://doi.org/10.1007/s00253-020-10814-6.
Article
CAS
PubMed
Google Scholar
Rawson TM, Wilson RC, Holmes A. Understanding the role of bacterial and fungal infection in COVID-19. Clin Microbiol Infect. 2021;27(1):9–11. https://doi.org/10.1016/j.cmi.2020.09.025.
Article
CAS
PubMed
Google Scholar
MacIntyre CR, Chughtai AA, Barnes M, et al. The role of pneumonia and secondary bacterial infection in fatal and serious outcomes of pandemic influenza a(H1N). BMC Infect Dis. 2018;18:637. https://doi.org/10.1186/s12879-018-3548-0.
Article
PubMed
PubMed Central
Google Scholar
Abelenda-Alonso G, Rombauts A, Gudiol C, et al. Influenza and bacterial coinfection in adults with community-acquired pneumonia admitted to conventional wards: risk factors, clinical features, and outcomes. Open Forum Infect Dis. 2020;7(3):ofaa066. https://doi.org/10.1093/ofid/ofaa066.
Article
PubMed
PubMed Central
Google Scholar
Waldeck F, Boroli F, Suh N, et al. Influenza-associated aspergillosis in critically-ill patients—a retrospective bicentric cohort study. Eur J Clin Microbiol Infect Dis. 2020;39(10):1915–23. https://doi.org/10.1007/s10096-020-03923-7 (Epub 2020 Jun 3. PMID: 32494955; PMCID: PMC7266735).
Article
CAS
PubMed
Google Scholar
Yap FH, Gomersall CD, Fung KS, et al. Increase in methicillin-resistant Staphylococcus aureus acquisition rate and change in pathogen pattern associated with an outbreak of severe acute respiratory syndrome. Clin Infect Dis. 2004;39(4):511–6. https://doi.org/10.1086/422641.
Article
PubMed
Google Scholar
Memish ZA, Almasri M, Turkestani A, Al-Shangiti AM, Yezli S. Etiology of severe community-acquired pneumonia during the 2013 Hajj-part of the MERS-CoV surveillance program. Int J Infect Dis. 2014;25:186–90. https://doi.org/10.1016/j.ijid.2014.06.003.
Article
PubMed
PubMed Central
Google Scholar
World Health Organization. COVID-19 Clinical Management. Living Guidance 25 January 2021. Available from: https://www.who/int/iris/handle/10665/338882. Accessed 6 Mar 2021.
Rawson TM, Moore LSP, Zhu N et al. Bacterial and fungal co-infection in individuals with coronavirus: a rapid review to support COVID-19 antimicrobial prescribing [Preprint]. Clin Infect Dis. 2020;530. https://doi.org/10.1093/cid/ciaa530.
Karami Z, Knoop BT, Dofferhoff ASM, et al. Few bacterial co-infections but frequent empiric antibiotic use in the early phase of hospitalized patients with COVID-19: results from a multicentre retrospective cohort study in The Netherlands. Infect Dis (Lond). 2021;53(2):102–10. https://doi.org/10.1080/23744235.2020.1839672.
Article
Google Scholar
Grau S, Echeverria-Esnal D, Gómez-Zorrilla S, et al. Evolution of antimicrobial consumption during the first wave of COVID-19 pandemic. Antibiotics. 2021;10(2):132. https://doi.org/10.3390/antibiotics10020132.
Article
CAS
PubMed
PubMed Central
Google Scholar
Vaughn VM, Gandhi T, Petty LA, et al. Empiric antibacterial therapy and community-onset bacterial co-infection in patients hospitalized with COVID-19: a multi-hospital cohort study. Clin Infect Dis. 2020;72:e533. https://doi.org/10.1093/cid/ciaa1239 (published online ahead of print, 2020 Aug 21).
Article
CAS
PubMed Central
Google Scholar
Somers EC, Eschenauer GA, Troost JP, et al. Tocilizumab for treatment of mechanically ventilated patients with COVID-19. Clin Infect Dis. 2020;73:e445. https://doi.org/10.1093/cid/ciaa954.
Article
CAS
Google Scholar
RECOVERY Collaborative Group, Horby P, Lim WS, Emberson JR, et al. Dexamethasone in hospitalized patients with COVID-19. N Engl J Med. 2021;384(8):693–704. https://doi.org/10.1056/NEJMoa2021436 (Epub 2020 Jul 17. PMID: 32678530; PMCID: PMC7383595).
Article
Google Scholar
Dimmig LM, Wu D, Gold M, et al. IL6 inhibition in critically ill COVID-19 patients is associated with increased secondary infections. medRxiv. 2020. https://doi.org/10.1101/2020.05.15.20103531.
Article
Google Scholar
Antimicrobial resistance in the age of COVID-19 [Editorial]. Nat Microbiol. 5:779 (2020). https://doi.org/10.1038/s41564-020-0739-4.
Getahun H, Smith I, Trivedi K, et al. Tackling antimicrobial resistance in the COVID-19 pandemic. Bull World Health Organ. 2020;98:442-442A.
Article
Google Scholar
Rodríguez-Baño J, Rossolini GM, Schultsz C, et al. AMR research in a post-pandemic world: Insights on antimicrobial resistance research in the COVID-19 pandemic. J Global Antimicrob Resist. 2021. https://doi.org/10.1016/j.jgar.2021.02.013.
Article
Google Scholar
Rossato L, Negrão FJ, Simionatto S. Could the COVID-19 pandemic aggravate antimicrobial resistance? Am J Infect Control. 2020;48:1129–30. https://doi.org/10.1016/j.ajic.2020.06.192 (Epub 2020 Jun 27. PMID: 32603851; PMCID: PMC7320258).
Article
PubMed
PubMed Central
Google Scholar
Adler H, Ball R, Fisher M, et al. Low rate of bacterial co-infection in patients with COVID-19. The Lancet Microbe. 2020;1:e62.
Article
CAS
Google Scholar
Youngs J, Wyncoll D, Hopkins P, et al. Improving antibiotic stewardship in COVID-19: bacterial co-infection is less common than with influenza. J Infect. 2020;81(3):e55–7. https://doi.org/10.1016/j.jinf.2020.06.056.
Article
CAS
PubMed
PubMed Central
Google Scholar
Zhu X, Ge Y, Wu T, et al. Co-infection with respiratory pathogens among COVID-2019 cases. Virus Res. 2020;285:198005. https://doi.org/10.1016/j.virusres.2020.198005.
Article
CAS
PubMed
PubMed Central
Google Scholar
Huttner BD, Catho G, Pano-Pardo JR, et al. COVID-19: don’t neglect antimicrobial stewardship principles! Clin Microbiol Infect. 2020;26:808–10. https://doi.org/10.1016/j.cmi.2020.04.024.
Article
CAS
PubMed
PubMed Central
Google Scholar
Verroken A, Scohy A, Gerard L, et al. Co-infections in COVID-19 critically ill and antibiotic management: a prospective cohort analysis. Crit Care. 2020;24:410. https://doi.org/10.1186/s13054-020-03135-7.
Article
PubMed
PubMed Central
Google Scholar
Hughes S, Troise O, Donaldson H, et al. Bacterial and fungal coinfection among hospitalised patients with COVID-19: a retrospective cohort study in a UK secondary care setting. Clin Microbiol Infect. 2020;26(10):1395–9. https://doi.org/10.1016/j.cmi.2020.06.025 (Epub 2020 Jun 27. PMID: 32603803; PMCID: PMC7320692).
Article
CAS
PubMed
PubMed Central
Google Scholar
Garcia-Vidal C, Sanjuan G, Moreno-García E, et al. Incidence of co-infections and superinfections in hospitalized patients with COVID-19: a retrospective cohort study. Clin Microbiol Infect. 2021;27(1):83–8. https://doi.org/10.1016/j.cmi.2020.07.041 (Epub 2020 Jul 31).
Article
CAS
PubMed
Google Scholar
Contou D, Claudinon A, Pajot O, et al. Bacterial and viral co-infections in patients with severe SARS-CoV-2 pneumonia admitted to a French ICU. Ann Intensive Care. 2020;10:119. https://doi.org/10.1186/s13613-020-00736-x.
Article
CAS
PubMed
PubMed Central
Google Scholar
Neto AGM, Lo KB, Wattoo A, et al. Bacterial infections and patterns of antibiotic use in patients with COVID-19. J Med Virol. 2021;93:1489–95. https://doi.org/10.1002/jmv.26441.
Article
CAS
Google Scholar
Nori P, Cowman K, Chen V, et al. Bacterial and fungal coinfections in COVID-19 patients hospitalized during the New York City pandemic surge. Infect Control Hosp Epidemiol. 2021;42(1):84–8. https://doi.org/10.1017/ice.2020.368.
Article
CAS
PubMed
Google Scholar
Clancy CJ, Nguyen MH. Coronavirus disease 2019, superinfections, and antimicrobial development: what can we expect? Clin Infect Dis. 2020;71(10):2736–43. https://doi.org/10.1093/cid/ciaa524.PMID:32361747;PMCID:PMC7197597.
Article
CAS
PubMed
Google Scholar
M. Vaillancourt, Jorth P. The unrecognized threat of secondary bacterial infections with COVID-19. mBio. 2020;11. https://doi.org/10.1128/mBio.01806-20.
Dudoignon E, Caméléna F, Deniau B, et al. Bacterial pneumonia in COVID-19 critically ill patients: a case series. Clin Infect Dis. 2021;72(5):905–6. https://doi.org/10.1093/cid/ciaa762.
Article
PubMed
Google Scholar
Adler H, Ball R, Fisher M, et al. Low rate of bacterial co-infection in patients with COVID-19. Lancet Microbe. 2020;1(2): e62. https://doi.org/10.1016/S2666-5247(20)30036-7.
Article
CAS
PubMed
PubMed Central
Google Scholar
Lansbury L, Lim B, Baskaran V, Lim WS. Co-infections in people with COVID-19; a systemic review and meta-analysis. J Infection. 2020;81:266–75. https://doi.org/10.1016/j.inf2020.05.046.
Article
CAS
Google Scholar
Wu C-P, Adhi F, Highland K. Recognition and management of respiratory coinfection and secondary pneumonia in patients with COVID-19. Cleveland Clin J Med. 2020. https://doi.org/10.3949/ccjm87a.ccc015.
Article
Google Scholar
Falcone M, Tiseo G, Giordano C, et al. Predictors of hospital-acquired bacterial and fungal superinfections in COVID-19: a prospective observational study. J Antimicrob Chemother. 2021;76(4):1078–84. https://doi.org/10.1093/jac/dkaa530.
Article
CAS
PubMed
Google Scholar
Borman AM, Palmer MD, Fraser M, et al. COVID-19-associated invasive aspergillosis: data from the UK National Mycology Reference Laboratory. J Clin Microbiol. 2020;59(1):e02136. https://doi.org/10.1128/JCM.02136-20.
Article
PubMed
PubMed Central
Google Scholar
Kim KW, Deveson IW, Pang CNI, et al. Respiratory viral co-infections among SARS-CoV-2 cases confirmed by virome capture sequencing. Sci Rep. 2021;11:3934. https://doi.org/10.1038/s41598-021-83642-x.
Article
CAS
PubMed
PubMed Central
Google Scholar
Zhou P, Liu Z, Chen Y, et al. Bacterial and fungal infections in COVID-19 patients: a matter of concern [letter to the editor]. Infect Control Hosp Epidemiol. 2020;41:1124. https://doi.org/10.1017/ice.2020.156.
Article
CAS
PubMed
Google Scholar
Cheng B, Hu J, Zuo X, et al. Predictors of progression from moderate to severe coronavirus disease 2019: a retrospective cohort. Clin Micro Infect. 2020. https://doi.org/10.1016/j.cmi.2020.06.033.
Article
Google Scholar
Bengoechea JA, Bamford CG. SARS-CoV-2, bacterial co-infections, and AMR: the deadly trio in COVID-19? EMBO Mol Med. 2020;12(7):e12560. https://doi.org/10.15252/emmm.202012560 (Epub 2020 Jun 15. PMID: 32453917; PMCID: PMC7283846).
Article
CAS
PubMed
PubMed Central
Google Scholar
Townsend L, Hughes G, Kerr C, et al. Bacterial pneumonia coinfection and antimicrobial therapy duration in SARS-CoV-2 (COVID-19) infection. JAC-Antimicrob Resist. 2020;2. https://doi.org/10.1093/jacamr/dlaa071.
Vaillancourt M, Jorth P. The unrecognized threat of secondary bacterial infections with COVID-19. MBio. 2020;11(4):e01806. https://doi.org/10.1128/mBio.01806-20.
Article
CAS
PubMed
PubMed Central
Google Scholar
Rawson TM, Moore LSP, Castro-Sanchez E, et al. COVID-19 and the potential long-term impact on antimicrobial resistance. J Antimicrob Chemother. 2020;75:1681–4. https://doi.org/10.1093/jac/dkaa194.
Article
CAS
PubMed
Google Scholar
Clancy CJ, Buehrle DJ, Nguyen MH. PRO: the COVID-19 pandemic will result in increased antimicrobial resistance rates. JAC Antimicrob Resist. 2020. https://doi.org/10.1093/jacamr/dlaa049.
Article
PubMed
PubMed Central
Google Scholar
Callignon P, Beggs JJ. CON: COVID-19 will not result in increased antimicrobial resistance prevalence. JAC Antimicrob Resist. 2020. https://doi.org/10.1093/jacamr/dlaa051.
Article
Google Scholar
Mirzaei R, Goodarzi P, Asadi M, et al. Bacterial co-infections with SARS-CoV-2. IUBMB Life. 2020;72:2097–111. https://doi.org/10.1002/iub.2356.
Article
CAS
PubMed
Google Scholar
Intra J, Sarto C, Beck E, et al. Bacterial and fungal colonization of the respiratory tract in COVID-19 patients should not be neglected. Am J of Infect. 2020;48(9):1130–1. https://doi.org/10.1016/j.ajic.2020.06.185.
Article
Google Scholar
Pickens CO, Gao CA, Cuttica MJ et al. Bacterial superinfection pneumonia in patients mechanically ventilated for COVID-19 pneumonia. Am J Resp Crit Care Med. https://doi.org/10.1164/rccm.202106-1354OC.
Cataño-Correa JC, Cardona-Arias JA, Porras Mancilla JP, et al. Bacterial superinfection in adults with COVID-19 hospitalized in two clinics in Medellín-Colombia, 2020. PLoS ONE. 2021;16(7): e0254671. https://doi.org/10.1371/journal.pone.0254671.PMID:34255801;PMCID:PMC8277025.
Article
PubMed
PubMed Central
Google Scholar
Clancy CJ, Schwartz IS, Kula B, et al. Bacterial superinfections among persons with coronavirus disease 2019: a comprehensive review of data from postmortem studies. Open Forum Infect Dis. 2021;8(3):065. https://doi.org/10.1093/ofid/ofab065 (PMID: 33732753; PMCID: PMC7928570).
Article
Google Scholar
Grasselli G, Scaravilli V, Mangioni D, et al. Hospital-acquired infections in critically ill patients with COVID-19. Chest. 2021;160(2):454–65.
Article
CAS
Google Scholar
Meawed TE, Ahmed SM, Mowafy SMS, et al. Bacterial and fungal ventilator associated pneumonia in critically ill COVID-19 patients during the second wave. J Infect Public Health. 2021. https://doi.org/10.1016/j.jiph.2021.08.003 (Epub ahead of print. PMID: 34420902; PMCID: PMC8349397).
Article
PubMed
PubMed Central
Google Scholar
Gudiol C, Durà-Miralles X, Aguilar-Company J, et al. Co-infections and superinfections complicating COVID-19 in cancer patients: a multicentre, international study. J Infect. 2021;83(3):306–13. https://doi.org/10.1016/j.jinf.2021.07.014 (Epub ahead of print. PMID: 34302864; PMCID: PMC8295054).
Article
CAS
PubMed
PubMed Central
Google Scholar
Gaibani P, Viciani E, Bartoletti M, et al. The lower respiratory tract microbiome of critically ill patients with COVID-19. Sci Rep. 2021;11(1):10103. https://doi.org/10.1038/s41598-021-89516-6.PMID:33980943;PMCID:PMC8115177.
Article
CAS
PubMed
PubMed Central
Google Scholar
Montrucchio G, Corcione S, Sales G, et al. Carbapenem-resistant Klebsiella pneumoniae in ICU-admitted COVID-19 patients: Keep an eye on the ball. J Glob Antimicrob Resist. 2020;23:398–400. https://doi.org/10.1016/j.jgar.2020.11.004 (Epub 2020 Nov 23. PMID: 33242674; PMCID: PMC7682477).
Article
CAS
PubMed
PubMed Central
Google Scholar
Patel A, Emerick M, Cabunoc MK, et al. Rapid spread and control of multidrug-resistant gram-negative bacteria in COVID-19 patient care units. Emerg Infect Dis. 2021;27(4):1234–7. https://doi.org/10.3201/eid2704.204036 (Epub 2021 Feb 10. PMID: 33565961; PMCID: PMC8007317).
Article
CAS
PubMed
PubMed Central
Google Scholar
Fekkar A, Lampros A, Mayaux J, et al. Occurrence of invasive pulmonary fungal infections in patients with severe COVID-19 admitted to the ICU. Am J Respir Crit Care Med. 2021;203(3):307–17. https://doi.org/10.1164/rccm.202009-3400OC.PMID:33480831;PMCID:PMC7874326.
Article
CAS
PubMed
PubMed Central
Google Scholar
Lahmer T, Kriescher S, Herner A, et al. Invasive pulmonary aspergillosis in critically ill patients with severe COVID-19 pneumonia: results from the prospective AspCOVID-19 study. PLoS ONE. 2021;16(3): e0238825. https://doi.org/10.1371/journal.pone.0238825.PMID:33730058;PMCID:PMC7968651.
Article
CAS
PubMed
PubMed Central
Google Scholar
Al-Tawfiq JA, Alhumaid S, Alshukairi AN, et al. COVID-19 and mucormycosis superinfection: the perfect storm. Infection. 2021;24:1–21. https://doi.org/10.1007/s15010-021-01670-1 (Epub ahead of print. PMID: 34302291; PMCID: PMC8302461).
Article
CAS
Google Scholar
Chong WH, Saha BK, Ananthakrishnan R, et al. State-of-the-art review of secondary pulmonary infections in patients with COVID-19 pneumonia. Infection. 2021;49(4):591–605. https://doi.org/10.1007/s15010-021-01602-z (Epub 2021 Mar 11. PMID: 33709380; PMCID: PMC7951131).
Article
CAS
PubMed
Google Scholar
Wicky PH, Niedermann MS, Timsit JF. Ventilator-associated pneumonia in the era of COVID-19 pandemic: how common and what is the impact? Crit Care. 2021;25(1):153. https://doi.org/10.1186/s13054-021-03571-z.PMID:33882991;PMCID:PMC8059113.
Article
PubMed
PubMed Central
Google Scholar
Oliva A, Ceccarelli G, Borrazzo C, et al. Comparison of clinical features and outcomes in COVID-19 and influenza pneumonia patients requiring intensive care unit admission. Infection. 2021;26:1–11. https://doi.org/10.1007/s15010-021-01624-7 (Epub ahead of print. PMID: 34036458; PMCID: PMC8149291).
Article
CAS
Google Scholar
Ceccarelli G, Alessandri F, Oliva A, et al. Superinfections in patients treated with Teicoplanin as anti-SARS-CoV-2 agent. Eur J Clin Invest. 2021;51(1): e13418. https://doi.org/10.1111/eci.13418.
Article
CAS
PubMed
Google Scholar
Bassetti M, Kollef MH, Timsit JF. Bacterial and fungal superinfections in critically ill patients with COVID-19. Intensive Care Med. 2020;46(11):2071–4. https://doi.org/10.1007/s00134-020-06219-8 (Epub 2020 Sep 9. PMID: 32902729; PMCID: PMC7479998).
Article
CAS
PubMed
Google Scholar
Musuuza JS, Watson L, Parmasad V, et al. Prevalence and outcomes of co-infection and superinfection with SARS-CoV-2 and other pathogens: a systematic review and meta-analysis. PLoS ONE. 2021;16(5): e0251170. https://doi.org/10.1371/journal.pone.0251170.PMID:33956882;PMCID:PMC8101968.
Article
CAS
PubMed
PubMed Central
Google Scholar
Buehler PK, Zinkernagel AS, Hofmaenner DA, et al. Bacterial pulmonary superinfections are associated with longer duration of ventilation in critically ill COVID-19 patients. Cell Rep Med. 2021;2(4): 100229. https://doi.org/10.1016/j.xcrm.2021.100229.
Article
PubMed
PubMed Central
Google Scholar
Maataoui N, Chemali L, Patrier J et al. Impact of rapid multiplex PCR on management of antibiotic therapy in COVID-19-positive patients hospitalized in intensive care unit. Eur J Clin Microbiol Infect Dis. 2021:1–8. https://doi.org/10.1007/s10096-021-04213-6. (Epub ahead of print. PMID: 33733394; PMCID: PMC7968559)
Lucien MAB, Canarie MF, Kilgore PE, et al. Antibiotics and antimicrobial resistance in the COVID-19 era: perspective from resource-limited settings. Int J Infect Dis. 2021;104:250–4. https://doi.org/10.1016/j.ijid.2020.12.087 (Epub 2021 Jan 9. PMID: 33434666; PMCID: PMC7796801).
Article
CAS
PubMed
PubMed Central
Google Scholar
Para O, Caruso L, Ronchetti M, et al. Superinfection with difficult-to-treat bacteria in COVID-19 patients: a call for compliance with diagnostic and antimicrobial stewardship. Intern Emerg Med. 2021;16(3):789–91. https://doi.org/10.1007/s11739-020-02537-3 (Epub 2020 Nov 22. PMID: 33222117; PMCID: PMC7680555).
Article
PubMed
Google Scholar
Rawson TM, Ming D, Ahmad R, et al. Antimicrobial use, drug-resistant infections and COVID-19. Nat Rev Microbiol. 2020;18(8):409–10. https://doi.org/10.1038/s41579-020-0395-y.PMID:32488173;PMCID:PMC7264971.
Article
CAS
PubMed
Google Scholar